Published in Clin Cancer Res on June 01, 2000
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst (1998) 5.05
Psychological support for patients undergoing breast cancer surgery: a randomised study. BMJ (1996) 4.11
Association of exogenous estrogen and endometrial carcinoma. N Engl J Med (1975) 3.89
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res (2000) 3.71
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Cerebral oxygenation measured by near-infrared spectroscopy: comparison with jugular bulb oximetry. Ann Thorac Surg (1996) 2.26
STAT signaling in head and neck cancer. Oncogene (2000) 2.19
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol (2001) 2.18
Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics. Br Med J (1979) 2.15
Formation of N-nitrosamines from secondary amines and nitrite in human and animal gastric juice. Food Cosmet Toxicol (1969) 2.15
A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med (1997) 1.99
A preliminary scanning electron microscopic study of root canals after endodontic procedures. J Endod (1975) 1.97
Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer. Urology (1999) 1.92
Early effects of HIV on CD4 lymphocytes in vivo. J Immunol (1987) 1.87
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res (1988) 1.84
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer (1984) 1.71
Bacteria-organic matter coupling and its significance for oceanic carbon cycling. Microb Ecol (1994) 1.66
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia (1998) 1.52
Lessons from history. Why radiologists lost coronary angiography and what can be done to prevent future similar losses. Invest Radiol (1994) 1.51
Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J (Clin Res Ed) (1986) 1.51
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci (1999) 1.49
Visual acuity following binocular deprivation in the cat. Brain Res (1980) 1.47
Complications of iliac artery stent deployment. J Vasc Surg (1996) 1.46
Clinical features and natural history of intramedullary spinal cord metastasis. Cancer (1985) 1.43
Angiographic localization of small bowel angiodysplasia with use of platinum coils. J Vasc Interv Radiol (1994) 1.42
Elective removal of an intramyocardial bullet. South Med J (2001) 1.42
A uterine fluid-mediated sperm-inhibitory system. Biol Reprod (1970) 1.41
Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am (1998) 1.40
Medical needs of children in institutions for the mentally retarded. Am J Public Health Nations Health (1969) 1.39
Entrapment of a folded-over introducer sheath in the iliofemoral artery: an unusual complication of PTCA guiding catheter exchange. Cathet Cardiovasc Diagn (1990) 1.39
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability. Br J Cancer (1981) 1.39
First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg (1997) 1.38
One stop breast clinics--victims of their own success? A prospective audit of referrals to a specialist breast clinic. Eur J Surg Oncol (2000) 1.38
Sheathless technique of Ash Split-Cath insertion. J Vasc Interv Radiol (2001) 1.38
Peroxidase-mediated antimicrobial activity of rat uterine fluid. Gynecol Invest (1970) 1.36
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res (2001) 1.35
Analysis of changes in eating behavior and weight loss in type II diabetic patients. Which behaviors to change. Diabetes Care (1989) 1.34
A new dental cement. Br Dent J (1968) 1.34
PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells. Oncogene (2009) 1.32
Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene (2010) 1.30
The source of H2O2 for the uterine fluid-mediated sperm-inhibitory system. Biol Reprod (1970) 1.28
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res (1999) 1.27
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol (2012) 1.27
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology (1997) 1.24
Release of metal ions from dental implant materials in vivo: determination of Al, Co, Cr, Mo, Ni, V, and Ti in organ tissue. J Biomed Mater Res (1991) 1.24
Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J Control Release (2004) 1.23
Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. Br J Cancer (1981) 1.23
Segregation and mapping of allozymes of the apple maggot fly. J Hered (1983) 1.23
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol (1986) 1.22
Psychosocial effects of radiotherapy after mastectomy. Br Med J (Clin Res Ed) (1987) 1.20
Nuclear oestrogen receptors and treatment of breast cancer. Lancet (1977) 1.20
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res (1997) 1.20
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem (2001) 1.19
Endovascular treatment of carotid and vertebral pseudoaneurysms with covered stents. AJNR Am J Neuroradiol (2008) 1.19
Atresia of Small Intestine; Two Case Reports; One Multiple Atresia, With Survival. Ann Surg (1944) 1.18
Catalogue of 45 reference Raman spectra of minerals concerning research in art history or archaeology, especially on corroded metals and coloured glass. Spectrochim Acta A Mol Biomol Spectrosc (2003) 1.18
Importance of continued testicular suppression in hormone-refractory prostate cancer. J Clin Oncol (1993) 1.18
Selenium content of food consumed by Canadians. J Nutr (1975) 1.17
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15
Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism (2001) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer. J Clin Oncol (2001) 1.15
On the causes of fevers (1839) by William Budd. Henry E Sigerist Suppl Bull Hist Med (1984) 1.14
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study. J Urol (2001) 1.13
Acquired extrinsic pulmonic stenosis caused by mediastinal tumors. Cancer (1982) 1.13
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res (1999) 1.12
Retrograde transport of toxins across the endoplasmic reticulum membrane. Biochem Soc Trans (2003) 1.12
Malposition of a total parenteral nutrition catheter in the accessory hemiazygos vein. JPEN J Parenter Enteral Nutr (1983) 1.10
Angiographic demonstration of bleeding in a unusually located Meckel's diverticulum simulating colonic bleeding. Cardiovasc Intervent Radiol (1990) 1.09
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res (2001) 1.09
Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res (2003) 1.08
STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br J Cancer (2006) 1.08
Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst (1998) 1.08
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer (1998) 1.08
The social, emotional and financial implications of adjuvant chemotherapy in breast cancer. Br J Surg (1981) 1.07
From extracellular to intracellular: the establishment of a symbiosis. Proc R Soc Lond B Biol Sci (1979) 1.07
Factors influencing options in primary breast cancer treatment. J Clin Oncol (1987) 1.07
Corynebacterium ulcerans infection associated with untreated milk. J Infect (1984) 1.07
Provision of health care for institutionalized retarded children. Am J Ment Defic (1968) 1.07
Validity of the General Health Questionnaire and its subscales in patients receiving chemotherapy for early breast cancer. J Psychosom Res (1988) 1.06
Scanning electron microscopy observations on the penetration and structure of resin tags in bleached and unbleached bovine enamel. J Endod (1991) 1.06
A review of the zinc polycarboxylate cements. J Can Dent Assoc (Tor) (1971) 1.06
Antimalarials. 16. Synthesis of 2-substituted analogues of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3- (trifluoromethyl)phenoxy]quinoline as candidate antimalarials. J Med Chem (1989) 1.05
Dental cements. Current status and future prospects. Dent Clin North Am (1983) 1.05
Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg (2001) 1.05
Post-training unilateral vagal stimulation enhances retention performance in the rat. Neurobiol Learn Mem (1995) 1.05
Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol (1992) 1.05
Intestinal perforation in Wegener's granulomatosis. Gut (1986) 1.04
High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. J Natl Cancer Inst (1992) 1.04
A phase II study of taxol in patients with malignant melanoma. Invest New Drugs (1991) 1.04
Bromide intoxication. Johns Hopkins Med J (1976) 1.04
Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes in the rat. Neurobiol Learn Mem (1998) 1.03
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab (1982) 1.01